Phase I Trial of Induction Paraplatin and Xeloda Followed by Concurrent Paraplatin and Xeloda With Intensity Modulated Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Trial Profile

Phase I Trial of Induction Paraplatin and Xeloda Followed by Concurrent Paraplatin and Xeloda With Intensity Modulated Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Aug 2007

At a glance

  • Drugs Capecitabine (Primary) ; Carboplatin
  • Indications Head and neck cancer; Orofacial cancer; Oropharyngeal cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 06 Aug 2007 Status changed from recruiting to completed.
    • 08 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top